Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Pliability × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1 Genitourinary 1 CNS 1

Conditions

Prostatic Neoplasms 1

Interventions

Radiosurgery 62 Magnetic Resonance Spectroscopy 39 Standard of Care 37 Radiotherapy 31 Exercise 30 Blood Specimen Collection 24 Early Intervention, Educational 22 Magnetic Resonance Imaging 19 Brachytherapy 19 Surveys and Questionnaires 18 Methods 17 Androgen Antagonists 17 Interviews as Topic 16 Therapeutics 15 Radiotherapy, Intensity-Modulated 15 Multiparametric Magnetic Resonance Imaging 15 Cystectomy 15 Biopsy 14 Psychiatric Rehabilitation 13 Practice Guidelines as Topic 13 Specimen Handling 12 Educational Status 11 Diet Therapy 11 Sunitinib 10 Radiation 10 gallium 68 PSMA-11 9 Surgical Procedures, Operative 9 Resistance Training 9 Prostatectomy 9 Watchful Waiting 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04485767 2024-08-20

RESIST-ADT (Androgen Deprivation Therapy)

Dana-Farber Cancer Institute

Phase NA Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡